142 related articles for article (PubMed ID: 20125121)
1. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer.
Crawford ED; Black L; Eaddy M; Kruep EJ
Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):162-7. PubMed ID: 20125121
[TBL] [Abstract][Full Text] [Related]
2. Cumulative cost pattern comparison of prostate cancer treatments.
Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
[TBL] [Abstract][Full Text] [Related]
3. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era.
Carter CA; Donahue T; Sun L; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Jackmaan S; Moul JW
J Clin Oncol; 2003 Nov; 21(21):4001-8. PubMed ID: 14581423
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
McNaughton-Collins M; Walker-Corkery E; Barry MJ
J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
[TBL] [Abstract][Full Text] [Related]
5. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
7. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
[TBL] [Abstract][Full Text] [Related]
8. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
Brandeis J; Pashos CL; Henning JM; Litwin MS
Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the prostate: an expensive way to die.
Piper NY; Kusada L; Lance R; Foley J; Moul J; Seay T
Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
[TBL] [Abstract][Full Text] [Related]
10. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer.
Jayadevappa R; Bloom BS; Chhatre S; Fomberstein KM; Wein AJ; Malkowicz SB
J Urol; 2005 Sep; 174(3):1059-64; discussion 1064. PubMed ID: 16094058
[TBL] [Abstract][Full Text] [Related]
11. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).
Andersson SO; Andrén O; Lyth J; Stark JR; Henriksson M; Adami HO; Carlsson P; Johansson JE
Scand J Urol Nephrol; 2011 Apr; 45(3):177-83. PubMed ID: 21265595
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer--prevalence-based healthcare costs.
Norlund A; Alvegård T; Lithman T; Merlo J; Noreen D
Scand J Urol Nephrol; 2003; 37(5):371-5. PubMed ID: 14594683
[TBL] [Abstract][Full Text] [Related]
13. The economic burden of prostate cancer, California, 1998.
Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
[TBL] [Abstract][Full Text] [Related]
14. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
15. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
Balu S
Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
[TBL] [Abstract][Full Text] [Related]
16. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
18. An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia.
Black L; Naslund MJ; Gilbert TD; Davis EA; Ollendorf DA
Am J Manag Care; 2006 Mar; 12(4 Suppl):S99-S110. PubMed ID: 16551208
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer in Victoria in 1993: patterns of reported management.
Frydenberg M; Giles GG; Mameghan H; Thursfield VJ; Millar J; Wheelahan JB; Bolton DM; Syme RR
Med J Aust; 2000 Mar; 172(6):270-4. PubMed ID: 10860092
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer.
Penson DF; Chan JM;
J Urol; 2007 Jun; 177(6):2020-9. PubMed ID: 17509282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
